High Content Screening System

The organoid technology is gaining prominence in drug discovery research. We will hold a Japanese webinar where you can learn about the automation of culture through AI image analysis and the reduction of drug discovery risks through the utilization of multimodal data, all in one session. We will introduce technologies that quantify organoid culture using AI image analysis, enabling autonomous passaging decisions, as well as the latest examples of data utilization that integrate multi-omics data from patient-derived organoids (PDOs) to predict drug responses with high accuracy, thereby reducing drug discovery risks. These advancements are expected to enhance research reproducibility and promote precision medicine. A Q&A session is also planned after the presentations. Presentation 1: Automation of organoid culture through quantification of culture conditions and autonomous passaging decisions using AI image analysis Koji Utagawa, Application Scientist, Molecular Devices Japan, Ph.D. in Science Presentation 2: Risk reduction in cancer drug projects using molecular and multi-omics data from organoids Toshiya Kondo, Scientific Business Consultant, Genedata AG, M.D.